Subscribe to our RSS feeds RSS | Login | Register  
 

Richard Vanderveer

 
 

Recent Articles

Vantage Point

July 14, 2008

As I write this, I have just returned from The Pharmaceutical Business Intelligence and Research Group annual general meeting in Washington, DC.

Vantage Point

July 01, 2008

As pharmaceutical marketing researchers, we must be mindful that the federal government is not only involved in the regulation of the drug industry, but the 50 state governments are as well.

Vantage Point

June 01, 2008

We are witnessing the death of pharma marketing research and the birth of healthcare marketing research.

Vantage Point

May 01, 2008

I recently attended the PMRG conference in Phoenix, and came away with several realizations.

Vantage Point

April 01, 2008

I'll bet that if you hear one more person in our industry talk about the pressure being applied on marketing researchers to do more with less, you will scream.

Vantage Point

March 01, 2008

As this is being written, word came across that IMS, that venerable organization of pharma marketing research, was about to lay off 10% of its work force.

Vantage Point

February 01, 2008

A document recently crossed my desk that was so seminal I needed to share it with my colleagues through this column.

Vantage Point

January 01, 2008

In December we predicted a wild ride in 2008 for pharmaceutical marketing research.

Vantage Point

December 01, 2007

For pharmaceutical marketing research, I believe that 2007 constituted a tipping point.

Vantage Point

November 01, 2007

Good, old-fashioned pharmaceutical marketing research--comparing Product A and Product B--is still being conducted, but the drop in genuinely new molecules has substantially reduced the amount.